BIOCODEX LAB has a total of 11 patent applications. Its first patent ever was published in 1984. It filed its patents most often in United States, EPO (European Patent Office) and France. Its main competitors in its focus markets pharmaceuticals, environmental technology and machines are VIROGEN LTD, MORTON GROVE PHARMACEUTICALS I and LEES ANDREW.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | France | 2 | |
#4 | Canada | 1 | |
#5 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Unspecified technologies | |
#3 | Climate change adaptation technologies | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hublot Bernard | 8 |
#2 | Blehaut Henri | 4 |
#3 | Hublot Bernard M | 3 |
#4 | Levy Rene H | 2 |
#5 | Tor Jacques A | 2 |
#6 | Lockard Joan S | 2 |
#7 | Finnell Richard H | 2 |
#8 | Osowska Vincent Sylwia | 1 |
#9 | Gayral Philippe | 1 |
#10 | Levy Rene Hanania | 1 |
Publication | Filing date | Title |
---|---|---|
FR2711528A1 | Use of Saccharomyces yeasts for the manufacture of a medicament against cryptosporidiosis. | |
US5095033A | Method for treating epilepsy | |
EP0195870A1 | Use of saccharomyces yeast in the manufacture of a medicament against amoebiasis | |
US4595590A | Method for preventing or treating pseudo-membranous colitis |